Table 2.
Parameter | ER (n=53) | NER (n=58) | p |
---|---|---|---|
Tumor size(cm)* | 1.730.61 | 1.760.64 | 0.795 |
Nonrim APHE | 0.185 | ||
present | 44 (83.0) | 53 (91.4) | |
absent | 9 (17.0) | 5 (8.6) | |
Washout | 0.112 | ||
present | 36 (67.9) | 47 (81.0) | |
absent | 17 (32.1) | 11 (19.0) | |
Enhancing capsule | 0.019 | ||
present | 23 (43.4) | 38 (65.5) | |
absent | 30 (56.6) | 20 (34.5) | |
Restricted diffusion | 0.096 | ||
present | 39 (73.6) | 50 (86.2) | |
absent | 14 (26.4) | 8 (13.8) | |
Mild-moderate T2 hyperintensity | 0.069 | ||
present | 42 (79.2) | 53 (91.4) | |
absent | 11 (20.8) | 5 (8.6) | |
Hepatobiliary phase hypointensity | 0.289 | ||
present | 45 (84.9) | 53 (91.4) | |
absent | 8 (15.1) | 5 (8.6) |
Unless otherwise indicated, data are numbers of patients, with percentage in parentheses.
*Data are meansstandard deviation. P values that are statistically significant are in bold.
HCC, Hepatocellular carcinoma; ER, Early recurrence; NER, None early recurrence; APHE, Arterial phase hyperenhancement.